Because Expertise Matters
Join Cyberounds®, an online education community for health professionals Sign Up

Log In

Evaluation and Treatment of Polycystic Ovary Syndrome

A 32-year-old obese woman complains of recurrent yeast infections. She was diagnosed with polycystic ovary syndrome (PCOS) at the age of 16 years, based on irregular menstrual periods, recalcitrant acne...
CME credit is no longer available for this conference.

Course Authors

Daniel A. Dumesic, M.D., Mark O. Goodarzi, M.D., Ph.D., Gregory D. Chazenbalk, Ph.D., David Geller, M.D., and David H. Abbott, Ph.D.

Dr. Dumesic is Professor and Division Chief of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of California Los Angeles; Dr. Goodarzi is Associate Professor, Director of Endocrinology, Diabetes, and Metabolism, Cedars-Sinai Medical Center, Los Angeles, CA; Dr. Chazenbalk is Associate Researcher, Department of Obstetrics and Gynecology, University of California Los Angeles; and Dr. Geller is Associate Professor of Pediatrics, Ahmanson Department of Pediatrics, Cedars-Sinai Medical Center, Los Angeles, CA; and Dr. Abbott is Professor, Wisconsin National Primate Research Center and Department of Obstetrics and Gynecology, University of Wisconsin, Madison, WI.

Within the past 12 months Drs. Dumesic, Goodarzi, Chazenbalk and Geller report no commercial conflicts of interest; Dr. Abbott has received research grants from Boehringer-Ingelheim and Viamet, and been a consultant to Viamet.

Albert Einstein College of Medicine, CCME staff and interMDnet staff have nothing to disclose.

Estimated course time: 1 hour(s).

Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Learning Objectives

Upon completion of this Cyberounds®, you should be able to:

  • Outline a metabolic evaluation for a woman with PCOS

  • Prepare ovulation induction for an anovulatory PCOS patient wishing to conceive

  • Describe a pubertal abnormality that can occur in PCOS adolescents

  • Discuss the pregnancy-related consequences of PCOS on maternal-fetal health.



The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.


Please click below to accept the terms of this CME activity

Courses You Might Like

Caring for Women and Their Families: The Essential Role of Reproductive Rights

Editor's Note: Dr. Stotland is the author/editor of several books on reproductive healthcare: Abortion: Facts and Feelings; Social Change and Women's Reproductive Health; Psychological Aspects of Women’s Health Care: The Interface Between Psychiatry and Obstetrics and Gynecology and Psychiatric Aspects of Reproductive Technology. From 2008-2008, she was the president of the American Psychiatric Association. We invite your comments on this Cyberounds® and will publish a representative sample. Generally, rights in medical care are actions which care
Authors: Nada L. Stotland, M.D., M.P.H.
Estimated Time: 1 Hour

Current and Emerging Therapies for Vulvo-vaginal Atrophy

This presentation may include discussion of commercial products and services. Vulvo-vaginal atrophy (VVA) in peri- and post-menopausal women is caused by declining, then deficient estrogen levels. It frequently results in distressing symptoms that include burning, irritation, discharge and dyspareunia. A Cochrane review (2006) estimates that in healthy women over age 60, 50% experience one or more of these symptoms. Other studies report a similar estimated prevalence of 39-47%, with up to 52% of those affected reporting these
Authors: Nancy A. Phillips, M.D., and Gloria A. Bachmann, M.D.
Estimated Time: 1 Hour

Current Management of Endometriosis

This Cyberounds® will discuss unlabeled use of low-dose estrogen, norethindrone and aromatase inhibitors. Endometriosis remains one of the most complex pathologies faced by OBGYNs and primary care physicians. The overall prevalence of endometriosis in reproductive age women has been estimated to be between 3-10%, but can vary depending on the population studied. Endometriosis affects 12-32% of reproductive age women with pelvic pain and 9-50% of women who are infertile. It is
Authors: Kenan Omurtag, M.D., and Amber R. Cooper, M.D., M.S.C.I.
Estimated Time: 1 Hour

Endometrial Cancer

Type I Tumors Endometrial hyperplasia is thought to be the precursor lesion of these well- to moderately-differentiated endometrioid adenocarcinomas. In a classic study, Kurman et al. followed 170 patients with endometrial hyperplasia who did not undergo a hysterectomy for at least one year. The authors quantified the risk of progression to carcinoma in patients with various pre-cancerous changes. Cancer precursor lesions were classified as either lacking (hyperplasia) or displaying cytologic atypia (atypical hyperplasia). Hyperplasia and atypical hyperplasia were further
Authors: Yevgeniya Ioffe, M.D., and Israel Zighelboim, M.D.
Estimated Time: 1 Hour

Central Nervous System-selective Estrogens: A Safe Estrogen Therapy

Following the publication of the book “Feminine Forever” by Robert Wilson in 1966, the use of hormone replacement therapy (HRT or HT) became popular. In the 1980s, numerous observational studies added further support to the concept that HRT would prevent not only hot flashes and osteoporosis but also heart disease, urinary incontinence and dementia, and would thus improve the quality of life. However, in 1998, the Heart and Estrogen/Progestin Replacement Study (HERS) concluded that the combination of estrogen and progestin
Authors: Istvan Merchenthaler, M.D., Ph.D., D.Sc. and Laszlo Prokai, Ph.D., D.Sc.
Estimated Time: 1 Hour

Diagnosis and Treatment of Epithelial Ovarian Cancer

The majority of patients with ovarian cancer report symptoms prior to their diagnosis; unfortunately, these symptoms are often vague and nonspecific. A survey of 1,725 women with ovarian cancer in 2000 revealed that 95% of patients had symptoms prior to their diagnosis; interestingly, 89% of patients with early stage disease reported symptoms. A prospective study in 2004 demonstrated that bloating, urinary symptoms and increased abdominal size were associated with the development of ovarian cancer. Urinary frequency or
Authors: Renata Urban, M.D., and Jonathan S. Berek, M.D., M.S.S.
Estimated Time: 1 Hour